CARsgen Therapeutics Holdings Limited (HKG:2171)

HKG:2171 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	84.05	39.43	-	-	25.81	-
Cost of Revenue	41.55	24.68	-	-	-	-
Gross Profit	42.5	14.75	-	-	25.81	-
Selling, General & Admin	114.87	162.84	133.31	136.61	126.52	77.61
Research & Development	349.32	463.74	660.04	679.49	501.03	281.03
Other Operating Expenses	142.88	139.91	-8.3	-10.45	-14.34	-9.98
Operating Expenses	607.07	766.49	785.05	805.65	613.21	348.67
Operating Income	-564.57	-751.75	-785.05	-805.65	-587.4	-348.67
Interest Expense	-6.16	-5.71	-4.66	-15.52	-10.87	-13.48
Interest & Investment Income	17.95	41.92	72.79	27.57	9.61	0.76
Currency Exchange Gain (Loss)	31.07	-82.24	-30.47	-97.35	7.45	21.62
Other Non Operating Income (Expenses)	-	-	-	-	-4,156	-724.29
Pretax Income	-521.71	-797.79	-747.39	-890.95	-4,737	-1,064
Income Tax Expense	0.35	0.35	0.41	1.3	7.65	-
Net Income	-522.06	-798.13	-747.79	-892.25	-4,744	-1,064
Net Income to Common	-522.06	-798.13	-747.79	-892.25	-4,744	-1,064
Shares Outstanding (Basic)	550	553	556	552	387	198
Shares Outstanding (Diluted)	550	553	556	552	387	198
Shares Change (YoY)	-1.23%	-0.58%	0.82%	42.60%	95.23%	-
EPS (Basic)	-0.95	-1.44	-1.34	-1.62	-12.26	-5.37
EPS (Diluted)	-0.95	-1.44	-1.34	-1.62	-12.26	-5.37
Free Cash Flow	-368.05	-427.69	-463.77	-778.45	-688.16	-312.88
Free Cash Flow Per Share	-0.67	-0.77	-0.83	-1.41	-1.78	-1.58
Gross Margin	50.57%	37.41%	-	-	100.00%	-
Operating Margin	-671.74%	-1906.78%	-	-	-2275.59%	-
Profit Margin	-621.16%	-2024.43%	-	-	-18379.97%	-
Free Cash Flow Margin	-437.91%	-1084.81%	-	-	-2665.95%	-
EBITDA	-502.55	-686.61	-717.64	-748.73	-552.49	-316.4
D&A For EBITDA	62.02	65.14	67.41	56.92	34.91	32.27
EBIT	-564.57	-751.75	-785.05	-805.65	-587.4	-348.67

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.